Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open-Label Study of Levetiracetam in Body Dysmorphic Disorder.

Trial Profile

Open-Label Study of Levetiracetam in Body Dysmorphic Disorder.

Phase of Trial: Phase IV

Latest Information Update: 29 Jan 2018

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Somatoform disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Sep 2008 Actual end date (Jan 2008) added as reported by ClinicalTrials.gov.
    • 09 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top